DOI:
10.1055/s-00000021
Gesundheitsökonomie & Qualitätsmanagement
LinksClose Window
References
Beard SM, Maciver F, Clouth J. et al.
A decision model to compare health care costs of olanzapine and risperidone treatment for schizophrenia in Germany.
Eur J Health Econ 2006; 7: 165-172
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.